Adjuvant and neoadjuvant chemotherapy for MSI early gastric cancer: a systematic review and meta-analysis

Adjuvant and neoadjuvant chemotherapy for MSI early gastric cancer: a systematic review and meta-analysis

Background: Perioperative chemotherapy (CT) is an established therapeutic approach for patients diagnosed with stage IB–III gastric cancer (GC). Objectives: This study aimed to investigate the efficacy of this approach in individuals with GC exhibiting high microsatellite instability (MSI-H). Design...

Full description

Bibliographic Details
Main Authors:	Fausto Petrelli, Maria Antista, Francesca Marra, Fulvia Milena Cribiu’, Valentina Rampulla, Filippo Pietrantonio, Lorenzo Dottorini, Michele Ghidini, Andrea Luciani, Alberto Zaniboni, Gianluca Tomasello
Format:	Article
Language:	English
Published:	SAGE Publishing 2024-02-01
Series:	Therapeutic Advances in Medical Oncology
Online Access:	https://doi.org/10.1177/17588359241231259

Similar Items

First line therapy in stage IV BRAF mutated colorectal cancer
by: Fausto Petrelli, et al.
Published: (2024-09-01)

Antibody-drug conjugates in treating older patients suffering from cancer: what is the real value?
by: Gianluca Perego, et al.
Published: (2021-12-01)

Different Chemotherapy Regimens and Pathologic Complete Response in Triple-Negative Breast Cancer: An Updated Network Meta-Analysis of Phase 3 Trials
by: Fausto Petrelli, et al.
Published: (2024-02-01)

Adjuvant and neoadjuvant chemotherapy in pancreatic ductal adenocarcinoma
by: Carl S. Leonhardt, MD, et al.
Published: (2020-03-01)

Neoadjuvant and adjuvant doxorubicin chemotherapy in a case of feline soft tissue sarcoma
by: Filippo Torrigiani, et al.
Published: (2019-07-01)

Better survival of patients with oligo- compared with polymetastatic cancers: a systematic review and meta-analysis of 173 studies [version 4; peer review: 2 approved]
by: Alice Indini, et al.
Published: (2022-05-01)

Neoadjuvant and Adjuvant Chemotherapy in Osteosarcoma (The Experience of HORC in the Shariati Hospital)
by: Alimoghadam K, et al.
Published: (2004-07-01)

Neoadjuvant and Adjuvant Chemotherapy in Osteosarcoma (The Experience of HORC in the Shariati Hospital)
by: K Alimoghadam, et al.
Published: (2004-03-01)

Adjuvant chemotherapy for resected triple negative breast cancer patients: A network meta-analysis
by: Fausto Petrelli, et al.
Published: (2023-02-01)

Comparison of responses to neoadjuvant and adjuvant chemotherapies in muscle-invasive bladder cancer
by: Serhat Sekmek, et al.
Published: (2023-11-01)

Trends in utilization of neoadjuvant and adjuvant chemotherapy for muscle invasive bladder cancer
by: Coleman McFerrin, et al.
Published: (2020-11-01)

Neoadjuvant Chemotherapy and Adjuvant Chemoradiation Therapy in the Treatment of Resected Gastric Adenocarcinoma: A Case Series
by: Christina Hadzitheodorou, et al.
Published: (2017-04-01)

Diagnosis of Mixed Adenoneuroendocrine Carcinoma (MANEC) after Neoadjuvant Chemotherapy for Pancreatic and Gastric Adenocarcinoma: Two Case Reports and a Review of the Literature
by: Ester Oneda, et al.
Published: (2019-06-01)

LIFE EXPECTANCY IN PATIENTS WITH STAGE III A NON-SMALL CELL LUNG CANCER (NSCLC) TREATED WITH NEOADJUVANT CHEMORADIOTHERAPY (NCRT), NEOADJUVANT CHEMOTHERAPY (NCT), NEOADJUVANT CHEMOTHERAPY + ADJUVANT RADIATION THERAPY (NCT + ADJUVANT RT)
by: Katerina Maliarchuk, et al.
Published: (2022-12-01)

Neoadjuvant or adjuvant chemotherapy: what is the best treatment of muscle invasive bladder cancer?
by: Nabil Ismaili, et al.
Published: (2011-09-01)

Clinical Outcomes of Neoadjuvant Versus Adjuvant Chemotherapy on Muscle-invasive Bladder Cancer
by: DENG Kangli, et al.
Published: (2019-04-01)

Neoadjuvant and adjuvant chemotherapy for muscle-invasive bladder cancer: The likelihood of initiation and completion
by: Ahmed Eldefrawy, et al.
Published: (2012-01-01)

Efficacy of Adjuvant Chemotherapy after Neoadjuvant FOLFIRINOX and Following Resection of Pancreatic Cancer
by: Huapyong Kang
Published: (2021-02-01)

The role of CDK4/6 inhibitors in older and younger patients with breast cancer: A systematic review and meta-analysis
by: Fausto Petrelli, et al.
Published: (2023-10-01)

Impact of neoadjuvant chemotherapy and postoperative adjuvant chemotherapy cycles on survival of patients with advanced-stage ovarian cancer.
by: Young Shin Chung, et al.
Published: (2017-01-01)

Feasibility study of adjuvant chemotherapy with S-1 after curative esophagectomy following neoadjuvant chemotherapy for esophageal cancer
by: Noriyuki Hirahara, et al.
Published: (2022-06-01)

A randomized phase 3 trial of total neoadjuvant therapy (induction chemotherapy, neoadjuvant chemoradiation, neoadjuvant chemotherapy, and surgery) vs. standard long-term chemoradiation therapy (neoadjuvant chemoradiation, surgery, and adjuvant chemotherapy) in locally advanced rectal cancer
by: Freshte Foroughi, et al.
Published: (2024-12-01)

Adjuvant chemotherapy may be unnecessary for ypT0-2N0 gastric cancer patients after neoadjuvant chemotherapy and curative gastrectomy
by: Xinxin Shao, et al.
Published: (2023-08-01)

Postoperative Adjuvant Chemotherapy Improved the Prognosis in Locally Advanced Cervical Cancer Patients With Optimal Response to Neoadjuvant Chemotherapy
by: Xiaojie Feng, et al.
Published: (2020-12-01)

The Impact of Neoadjuvant versus Adjuvant Chemotherapy on Survival Outcomes in Locally Advanced Breast Cancer
by: Farhad Ghasemi, et al.
Published: (2024-10-01)

Adjuvant Chemotherapy After Neoadjuvant Therapy and Surgery for Non-Small Cell Lung Cancer
by: Ryo Miyata, MD, PhD, et al.
Published: (2024-09-01)

Adjuvant vs. neoadjuvant chemotherapy: quality of life and psychosocial variables in women with breast cancer
by: Ana Sofia Santos, et al.
Published: (2022-10-01)

Hepatocellular carcinoma in patients with nonalcoholic fatty liver disease: A systematic review and meta-analysis
by: Fausto Petrelli, et al.
Published: (2022-08-01)

Combination of neoadjuvant and adjuvant chemotherapy with FOLFOX compared with adjuvant chemotherapy in management of locally advanced rectal cancers: a randomized trial of a promising therapeutic approach
by: Mandana Biniaz, et al.
Published: (2024-07-01)

Treatment times in breast cancer patients receiving neoadjuvant vs adjuvant chemotherapy: Is efficiency a benefit of preoperative chemotherapy?
by: Nicole M. Melchior, et al.
Published: (2020-04-01)

Neoadjuvant chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy followed by adjuvant chemotherapy in locally advanced nasopharyngeal carcinoma
by: Jiraporn Setakornnukul, et al.
Published: (2018-03-01)

Adjuvant and neoadjuvant therapies in melanoma
by: Teresa Amaral, et al.
Published: (2020-10-01)

Radical Prostatectomy in Multimodal Setting: Current Role of Neoadjuvant and Adjuvant Hormonal or Chemotherapy-Based Treatments
by: Marco Oderda, et al.
Published: (2025-02-01)

Neoadjuvant versus adjuvant chemotherapy in upper tract urothelial carcinoma: A nationwide cohort study
by: Jong Hyun Tae, et al.
Published: (2022-11-01)

Neoadjuvant and Adjuvant Chemotherapy for Variant Histology Bladder Cancers: A Systematic Review and Meta-Analysis
by: Ziwei Zhu, et al.
Published: (2022-07-01)

Efficacy and Safety of Neoadjuvant Chemotherapy Combined with Adjuvant Chemotherapy for Locally Advanced Colon Cancer: A Propensity Score-Matching Analysis
by: Wei Zeng, et al.
Published: (2022-10-01)

Laparoscopic gastrectomy for gastric carcinoma with neoadjuvant chemotherapy
by: Shimpei Furuta, et al.
Published: (2017-11-01)

The Sensitivity Prediction of Neoadjuvant Chemotherapy for Gastric Cancer
by: Juan Sun, et al.
Published: (2021-04-01)

Adjuvant and/or neoadjuvant therapy for gastric cancer? A perspective review
by: Rebekka Schirren, et al.
Published: (2015-01-01)

Real-world data on adjuvant capecitabine after standard neoadjuvant chemotherapy for triple negative breast cancer
by: Maria Fernanda Imperio Pereira, et al.
Published: (2024-08-01)